BeyondSpring Inc (BYSI)

BeyondSpring Inc (BYSI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $23M; returns 1 day -3.1%, 1 week -22.9%, 1 year -78.7%.

BeyondSpring Inc. (BYSI) is a global clinical-stage biopharmaceutical company focused on discovering and developing innovative cancer therapies. Its primary asset is Plinabulin, a first-in-class selective immunomodulating microtubule-binding agent (SIMBA) with a dual mechanism of action: as a direct anti-cancer agent and for the prevention of chemotherapy-induced neutropenia (CIN).

Groups BYSI belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Life Sciences
• Drug Discovery
• Immunotherapy
• R&D

BYSI financial model: income statement, cash flow and balance sheet